The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer.
Saved in:
| Title: | The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer. |
|---|---|
| Authors: | Mei, Jie1,2 (AUTHOR), Cai, Yun1 (AUTHOR), Chen, Lingyan1 (AUTHOR), Wu, Youqing3 (AUTHOR), Liu, Jiayu4 (AUTHOR), Qian, Zhiwen1 (AUTHOR), Jiang, Ying4 (AUTHOR), Zhang, Ping5 (AUTHOR), Xia, Tiansong6 (AUTHOR) xiats@njmu.edu.cn, Pan, Xiang3 (AUTHOR) xiangpan@jiangnan.edu.cn, Zhang, Yan1,4 (AUTHOR) fuyou2007@126.com |
| Source: | British Journal of Cancer. Nov2023, Vol. 129 Issue 10, p1645-1657. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-023-02432-6 |
